Article
Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type 1 diabetes--the PRODIA study.
Annals of the New York Academy of Sciences - 1 Oct 2006
Ljungberg Martin, Korpela Riita, Ilonen Jorma, Ludvigsson Johnny, Vaarala Outi
Abstract excerpt
The final aim of the PRODIA study is to determine whether the use of probiotics during the first 6 months of life decreases the appearance of type 1 diabetes mellitus (T1DM)-associated autoantibodies in children with genetic risk for T1DM. A pilot study including 200 subjects was planned to show whether the use of probiotics during the first 6 months of life is safe and feasible. The prevalence of autoantibodies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
